Novo Nordisk
NVO
#66
Rank
โ‚น22.141 T
Marketcap
โ‚น4,314
Share price
9.92%
Change (1 day)
-42.04%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚น1.797 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น47.21 Billion. In 2024 the company made an earning of โ‚น1.713 Trillion, an increase over its 2023 earnings that were of โ‚น1.395 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น1.797 T4.87%
2024 โ‚น1.713 T22.84%
2023 โ‚น1.395 T57.81%
2022 โ‚น884.09 B5.24%
2021 โ‚น840.10 B12.38%
2020 โ‚น747.54 B13.11%
2019 โ‚น660.91 B-3.45%
2018 โ‚น684.52 B1.88%
2017 โ‚น671.87 B4.3%
2016 โ‚น644.15 B10.32%
2015 โ‚น583.88 B7.47%
2014 โ‚น543.31 B3.4%
2013 โ‚น525.44 B19.09%
2012 โ‚น441.22 B15.58%
2011 โ‚น381.75 B16.58%
2010 โ‚น327.47 B25.66%
2009 โ‚น260.61 B10.68%
2008 โ‚น235.46 B55.82%
2007 โ‚น151.11 B7.02%
2006 โ‚น141.20 B19.05%
2005 โ‚น118.60 B10.55%
2004 โ‚น107.28 B
2002 โ‚น75.54 B-14.39%
2001 โ‚น88.24 B-52.82%
2000 โ‚น187.02 B250%
1999 โ‚น53.43 B31.21%
1998 โ‚น40.72 B34.31%
1997 โ‚น30.32 B11.46%
1996 โ‚น27.20 B9.03%
1995 โ‚น24.94 B-3.15%
1994 โ‚น25.75 B-0.67%
1993 โ‚น25.93 B45.38%
1992 โ‚น17.83 B-13.81%
1991 โ‚น20.69 B37.12%
1990 โ‚น15.09 B-0.79%
1989 โ‚น15.21 B26.2%
1988 โ‚น12.05 B24.97%
1987 โ‚น9.64 B-0.9%
1986 โ‚น9.73 B-7.78%
1985 โ‚น10.55 B24.87%
1984 โ‚น8.45 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.073 T-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.037 T 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น824.07 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น727.42 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA